hold on there's just too much going on in Congress lmao...
Extends biodefense briefings and assesses advanced biology risks.
Senators Kaine (D-VA) and Budd (R-NC)
In committee, no Senate vote yet
This bill extends the requirement for annual briefings on the National Biodefense Strategy. It also mandates a new analysis of national security risks from "engineering biology" (advanced biotech) and calls for recommendations to improve U.S. readiness against these risks. The bill was introduced by a bipartisan pair of senators, Tim Kaine (D-VA) and Ted Budd (R-NC), and is currently awaiting review by a Senate committee.
Introduced Apr 21, 2026
This bill was introduced in the Senate on April 21, 2026, and immediately referred to the Committee on Homeland Security and Governmental Affairs. Before it can become law, the committee must approve it, then the full Senate must pass it. If passed by the Senate, it would then need to pass the House of Representatives and be signed by the President.
If passed, the government's required annual briefings on the National Biodefense Strategy, which would have ended in 2025, will be extended for several more years. Additionally, federal agencies will be required to conduct a detailed analysis of how emerging 'engineering biology' (like synthetic biology) could pose risks to national security or public safety. This analysis will lead to new recommendations for modernizing safeguards, regulations, and research to protect against these potential threats while also promoting beneficial innovations in life sciences.
Supporters Say
Supporters argue this bill is crucial for protecting national security and public safety from evolving biological threats and technological advancements.
Critics Say
Potential critics might argue the bill creates unnecessary reporting burdens or could unintentionally slow down beneficial scientific innovation.
Those in favor would likely emphasize the importance of proactively addressing potential dangers from advanced biological research, ensuring the U.S. remains prepared for future biodefense challenges. They would see the extension of briefings and the mandated risk assessment as vital steps to staying ahead of threats. While no specific opposition is noted in the bill text, potential concerns could center on whether extensive new regulations might stifle the rapid pace of innovation in engineering biology, or if the analyses and recommendations duplicate existing efforts within federal agencies.